Home|Journals Follow on Twitter| Subscribe to List

Directory for Medical Articles

Open Access


Clozapine in treatment-resistant schizophrenia: follow-up study for three years

Özcan Uzun, Aytekin Özşahin, K. Nahit Özmenler, Ali Doruk, Salih Battal.

Object: In this open trial the efficacy and safety of clozapine in
treatment-resistant schizophrenic patients were investigated.

Method: Treatment-resistant 29 schizophrenic patients were
followed-up for three years. Drug efficacy was assessed by means
of the BPRS, SAPS, and SANS. Side effects were rated with
UKU side effect scale, EEG, biochemical and hormone analysis.

Results and Conclusion: At the end of 3rd year we found a decrease
of 41.1% in BPRS score, %49.0 in SAPS score, and %33.6
in SANS score compared with pretreatment scores. The most
common side effects were weight gain, hypersalivation, sedation,
and EEG abnormalities. The agranulocytosis, which was
reported as the most significant side effect, was not observed in
this study group.

Key words: clozapine, treatment-resistant schizophrenia, three years follow-up

Share this Article

Journal of Apitherapy


ScopeMed Home
Follow ScopeMed on Twitter
Author Tools
eJPort Journal Hosting
About ScopeMed
License Information
Terms & Conditions
Privacy Policy
Suggest a Journal
Publisher Login
Contact Us

The articles in Scopemed are open access articles licensed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License (https://creativecommons.org/licenses/by-nc-sa/4.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.
ScopeMed is a Database Service for Scientific Publications. Copyright © ScopeMed® Information Services.
Scopemed Buttons